Recombinant CD274 (Atezolizumab Biosimilar) anticorps

N° du produit ABIN6964422

Détail du produit anti-CD274 (Atezolizumab Biosimilar) anticorps

Antigène: CD274 (Atezolizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Monoclonal

Conjugué: Cet anticorp CD274 (Atezolizumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), ELISA

Fonction: Anti-PDL1 (atezolizumab biosimilar) mAb

Attributs du produit: MPDL3280A,RG7446

Purification: Purified from cell culture supernatant by affinity chromatography

Classe de qualité: Research Grade

Isotype: IgG1

Information d'application

Indications d'application: ELISA 1:5000-10000, Flow Cyt 1:100

Commentaires:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur CD274 (Atezolizumab Biosimilar)

Antigène: CD274 (Atezolizumab Biosimilar)

Autre désignation: PDL1 (Atezolizumab Biosimilar) (CD274 (Atezolizumab Biosimilar) Produits)

Synonymes: anticorps B7-H, anticorps B7H1, anticorps PD-L1, anticorps PDCD1L1, anticorps PDCD1LG1, anticorps PDL1, anticorps CD274 molecule, anticorps CD274

Classe de substances: Biosimilar

Sujet: Synonyms: PD-L1, CD274, B7-H1, PDCD1L1, PDCD1LG1

UniProt: Q9NZQ7